Safety and Immune Responses to Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccines Expressing Tetanus Toxin Fragment C

Carol O. Tacket(University of Maryland, Baltimore), Myron M. Levine(University of Maryland, Baltimore), Timothy Wyant(University of Maryland, Baltimore), Robert Edelman(University of Maryland, Baltimore), Steven S. Wasserman(University of Maryland, Baltimore), James P. Nataro(University of Maryland, Baltimore), Genevieve A. Losonsky(University of Maryland, Baltimore), Stephen Chatfield, James E. Galen, Gordon Dougan(University of Cambridge), Marcelo B. Sztein(University of Maryland, Baltimore)
Clinical Immunology
November 1, 2000
10.1006/clim.2000.4924
Cited by 75

Related Papers

Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
|Nature|2001|1.3k
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
|Nature|2022|1.2k
Typhoid Fever
|New England Journal of Medicine|2002|1.1k
SARS-CoV-2 evolution during treatment of chronic infection
|Nature|2021|1.1k